Trial Profile
A Randomized, Open-Label, Single-Dose, Four-Way Crossover Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System Versus IMITREX STATdose at Three Injection Sites in Healthy Adults.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Feb 2010
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Pharmacokinetics
- 01 Nov 2009 Tolerability data reported in Headache.
- 28 Jun 2008 Results presented at 50th Annual American Headache Society Meeting, Boston, Massachusetts, USA, 2008.
- 26 Feb 2008 New trial record.